Malignant tumors of the nose and paranasal sinuses: Hospital of the University of Pennsylvania experience 1990-1997

Ralph P Tufano, Nahush A. Mokadam, Kathleen T. Montone, Gregory S. Weinstein, Ara A. Chalian, Patricia F. Wolf, Randal S. Weber

Research output: Contribution to journalArticle

Abstract

We reviewed our experience with sinonasal malignancies, which comprise less than 1% of all cancers, in order to determine the spectrum of disease and outcome after treatment. The medical records of 48 patients with sinonasal malignancies treated between 1990-1997 were reviewed for epidemiologic characteristics, tumor location and histology, treatment modalities, and tumor recurrence. Mean age was 58.5 years and 46% were male. Multiple sites of origin were common, including maxillary sinus (83%), ethmoid sinus (35%), and nasal cavity (40%). The histologie spectrum included squamous cell carcinoma (46%), adenoid cystic carcinoma (6%), and miscellaneous others (48%). Treatment included surgery and adjuvant radiotherapy (XRT) (58%), surgery alone (27%), XRT and chemotherapy (6%), surgery- and chemotherapy (4%),and XRT alone (4%). Mean follow-up was 15 months (range 2-58). Recurrence was evident in nine patients (19%), 3 (33%) of whom had prior treatment before presenting to HUP. Of the six who recurred after initial treatment at HUP, five (83.3%) were treated with surgery and XRT and one (16.7%) was treated with surgery alone. Of the three that recurred after undergoing attempts at salvage (prior treatment and then treatment at HUP), one had received surgery alone followed by surgery and XRT, one had surgery and XRT followed by surgery and one had XRT followed by surgery alone. Our experience reveals surgery and XRT to be the modality of choice, particularly for advanced tumors, whereas surgery alone may be sufficient for small, well localized tumors. Neoadjuvanl chemotherapy may offer improved local control; the future role of endoscopic surgery warrants further investigation.

Original languageEnglish (US)
Pages (from-to)117-123
Number of pages7
JournalAmerican Journal of Rhinology
Volume13
Issue number2
StatePublished - 1999
Externally publishedYes

Fingerprint

Paranasal Sinuses
Nose
Neoplasms
Drug Therapy
Ethmoid Sinus
Therapeutics
Recurrence
Salvage Therapy
Adenoid Cystic Carcinoma
Adjuvant Radiotherapy
Maxillary Sinus
Nasal Cavity
Medical Records
Squamous Cell Carcinoma
Histology

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Tufano, R. P., Mokadam, N. A., Montone, K. T., Weinstein, G. S., Chalian, A. A., Wolf, P. F., & Weber, R. S. (1999). Malignant tumors of the nose and paranasal sinuses: Hospital of the University of Pennsylvania experience 1990-1997. American Journal of Rhinology, 13(2), 117-123.

Malignant tumors of the nose and paranasal sinuses : Hospital of the University of Pennsylvania experience 1990-1997. / Tufano, Ralph P; Mokadam, Nahush A.; Montone, Kathleen T.; Weinstein, Gregory S.; Chalian, Ara A.; Wolf, Patricia F.; Weber, Randal S.

In: American Journal of Rhinology, Vol. 13, No. 2, 1999, p. 117-123.

Research output: Contribution to journalArticle

Tufano, RP, Mokadam, NA, Montone, KT, Weinstein, GS, Chalian, AA, Wolf, PF & Weber, RS 1999, 'Malignant tumors of the nose and paranasal sinuses: Hospital of the University of Pennsylvania experience 1990-1997', American Journal of Rhinology, vol. 13, no. 2, pp. 117-123.
Tufano, Ralph P ; Mokadam, Nahush A. ; Montone, Kathleen T. ; Weinstein, Gregory S. ; Chalian, Ara A. ; Wolf, Patricia F. ; Weber, Randal S. / Malignant tumors of the nose and paranasal sinuses : Hospital of the University of Pennsylvania experience 1990-1997. In: American Journal of Rhinology. 1999 ; Vol. 13, No. 2. pp. 117-123.
@article{898eeb2e279c45848204609bdd8c7746,
title = "Malignant tumors of the nose and paranasal sinuses: Hospital of the University of Pennsylvania experience 1990-1997",
abstract = "We reviewed our experience with sinonasal malignancies, which comprise less than 1{\%} of all cancers, in order to determine the spectrum of disease and outcome after treatment. The medical records of 48 patients with sinonasal malignancies treated between 1990-1997 were reviewed for epidemiologic characteristics, tumor location and histology, treatment modalities, and tumor recurrence. Mean age was 58.5 years and 46{\%} were male. Multiple sites of origin were common, including maxillary sinus (83{\%}), ethmoid sinus (35{\%}), and nasal cavity (40{\%}). The histologie spectrum included squamous cell carcinoma (46{\%}), adenoid cystic carcinoma (6{\%}), and miscellaneous others (48{\%}). Treatment included surgery and adjuvant radiotherapy (XRT) (58{\%}), surgery alone (27{\%}), XRT and chemotherapy (6{\%}), surgery- and chemotherapy (4{\%}),and XRT alone (4{\%}). Mean follow-up was 15 months (range 2-58). Recurrence was evident in nine patients (19{\%}), 3 (33{\%}) of whom had prior treatment before presenting to HUP. Of the six who recurred after initial treatment at HUP, five (83.3{\%}) were treated with surgery and XRT and one (16.7{\%}) was treated with surgery alone. Of the three that recurred after undergoing attempts at salvage (prior treatment and then treatment at HUP), one had received surgery alone followed by surgery and XRT, one had surgery and XRT followed by surgery and one had XRT followed by surgery alone. Our experience reveals surgery and XRT to be the modality of choice, particularly for advanced tumors, whereas surgery alone may be sufficient for small, well localized tumors. Neoadjuvanl chemotherapy may offer improved local control; the future role of endoscopic surgery warrants further investigation.",
author = "Tufano, {Ralph P} and Mokadam, {Nahush A.} and Montone, {Kathleen T.} and Weinstein, {Gregory S.} and Chalian, {Ara A.} and Wolf, {Patricia F.} and Weber, {Randal S.}",
year = "1999",
language = "English (US)",
volume = "13",
pages = "117--123",
journal = "American Journal of Rhinology and Allergy",
issn = "1945-8924",
publisher = "OceanSide Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Malignant tumors of the nose and paranasal sinuses

T2 - Hospital of the University of Pennsylvania experience 1990-1997

AU - Tufano, Ralph P

AU - Mokadam, Nahush A.

AU - Montone, Kathleen T.

AU - Weinstein, Gregory S.

AU - Chalian, Ara A.

AU - Wolf, Patricia F.

AU - Weber, Randal S.

PY - 1999

Y1 - 1999

N2 - We reviewed our experience with sinonasal malignancies, which comprise less than 1% of all cancers, in order to determine the spectrum of disease and outcome after treatment. The medical records of 48 patients with sinonasal malignancies treated between 1990-1997 were reviewed for epidemiologic characteristics, tumor location and histology, treatment modalities, and tumor recurrence. Mean age was 58.5 years and 46% were male. Multiple sites of origin were common, including maxillary sinus (83%), ethmoid sinus (35%), and nasal cavity (40%). The histologie spectrum included squamous cell carcinoma (46%), adenoid cystic carcinoma (6%), and miscellaneous others (48%). Treatment included surgery and adjuvant radiotherapy (XRT) (58%), surgery alone (27%), XRT and chemotherapy (6%), surgery- and chemotherapy (4%),and XRT alone (4%). Mean follow-up was 15 months (range 2-58). Recurrence was evident in nine patients (19%), 3 (33%) of whom had prior treatment before presenting to HUP. Of the six who recurred after initial treatment at HUP, five (83.3%) were treated with surgery and XRT and one (16.7%) was treated with surgery alone. Of the three that recurred after undergoing attempts at salvage (prior treatment and then treatment at HUP), one had received surgery alone followed by surgery and XRT, one had surgery and XRT followed by surgery and one had XRT followed by surgery alone. Our experience reveals surgery and XRT to be the modality of choice, particularly for advanced tumors, whereas surgery alone may be sufficient for small, well localized tumors. Neoadjuvanl chemotherapy may offer improved local control; the future role of endoscopic surgery warrants further investigation.

AB - We reviewed our experience with sinonasal malignancies, which comprise less than 1% of all cancers, in order to determine the spectrum of disease and outcome after treatment. The medical records of 48 patients with sinonasal malignancies treated between 1990-1997 were reviewed for epidemiologic characteristics, tumor location and histology, treatment modalities, and tumor recurrence. Mean age was 58.5 years and 46% were male. Multiple sites of origin were common, including maxillary sinus (83%), ethmoid sinus (35%), and nasal cavity (40%). The histologie spectrum included squamous cell carcinoma (46%), adenoid cystic carcinoma (6%), and miscellaneous others (48%). Treatment included surgery and adjuvant radiotherapy (XRT) (58%), surgery alone (27%), XRT and chemotherapy (6%), surgery- and chemotherapy (4%),and XRT alone (4%). Mean follow-up was 15 months (range 2-58). Recurrence was evident in nine patients (19%), 3 (33%) of whom had prior treatment before presenting to HUP. Of the six who recurred after initial treatment at HUP, five (83.3%) were treated with surgery and XRT and one (16.7%) was treated with surgery alone. Of the three that recurred after undergoing attempts at salvage (prior treatment and then treatment at HUP), one had received surgery alone followed by surgery and XRT, one had surgery and XRT followed by surgery and one had XRT followed by surgery alone. Our experience reveals surgery and XRT to be the modality of choice, particularly for advanced tumors, whereas surgery alone may be sufficient for small, well localized tumors. Neoadjuvanl chemotherapy may offer improved local control; the future role of endoscopic surgery warrants further investigation.

UR - http://www.scopus.com/inward/record.url?scp=0033091141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033091141&partnerID=8YFLogxK

M3 - Article

C2 - 10219440

AN - SCOPUS:0033091141

VL - 13

SP - 117

EP - 123

JO - American Journal of Rhinology and Allergy

JF - American Journal of Rhinology and Allergy

SN - 1945-8924

IS - 2

ER -